{"nct_id":"NCT04628494","title":"A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2021-01-13","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2028-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GMAB"]}